Reuters logo
BRIEF-Novocure Receives Reimbursement Approval For Optune In Japan For Treatment Of Glioblastoma
December 1, 2017 / 3:20 PM / 12 days ago

BRIEF-Novocure Receives Reimbursement Approval For Optune In Japan For Treatment Of Glioblastoma

Dec 1 (Reuters) - Novocure Ltd:

* NOVOCURE RECEIVES REIMBURSEMENT APPROVAL FOR OPTUNE® IN JAPAN FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA

* NOVOCURE-‍JAPANESE MINISTRY OF HEALTH, LABOUR & WELFARE APPROVED RECOMMENDATION TO PROVIDE REIMBURSEMENT FOR OPTUNE TO TREAT NEWLY DIAGNOSED GLIOBLASTOMA​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below